Interleukin-17 and cystic fibrosis lung disease

American Journal of Respiratory and Critical Care Medicine

Volumn 185, Issue 1, 2012, Pages 108-109

  Brodlie, Malcolm ^a,b,c   Corris, Paul A ^a,c   Lordan, James ^a,c   Ward, Christopher ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Newcastle Upon Tyne Hospitals NHS Foundation Trust   (United Kingdom)

^c FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17;

BRONCHUS BIOPSY; CD4+ T LYMPHOCYTE; CYSTIC FIBROSIS; HUMAN; IMMUNOASSAY; INFLAMMATION; LETTER; LUNG FIBROSIS; LUNG LAVAGE; PATHOGENESIS; PRIORITY JOURNAL; TH17 CELL;

EID: 84855280774     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/ajrccm.185.1.108a     Document Type: Letter

References (6)

1. Tan HL, Regamey N, Brown S, Bush A, Lloyd CM, Davies JC. The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med 2011; 184:252-258.
2. Brodlie M, McKean MC, Johnson GE, Anderson AE, Hilkens CM, Fisher AJ, Corris PA, Lordan JL, Ward C. Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease. Eur Respir J 2011;37:1378-1385.
3. Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M, Kuchroo VK, Hafler DA. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008;454:350-352.
4. Vanaudenaerde BM, Verleden SE, Vos R, De Vleeschauwer SI, Willems- Widyastuti A, Geenens R, Van Raemdonck DE, Dupont LJ, Verbeken EK, Meyts I. Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders.Am J Respir Crit Care Med 2011;183: 977-986.
5. Decraene A, Willems-Widyastuti A, Kasran A, De Boeck K, Bullens DM, Dupont LJ. Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable cystic fibrosis patients. Respir Res 2010;11:177.
6. Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Natl Rev 2010;10:479-489.